Glutamatergic drugs in Parkinson's disease
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 55 (25-26) , 2067-2075
- https://doi.org/10.1016/0024-3205(94)00387-4
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administrationEuropean Journal of Pharmacology, 1990
- Excitotoxicity and N‐methyl‐D‐Aspartate receptorsDrug Development Research, 1989
- Selective Destruction of Cultured Dopaminergic Neurons from Fetal Rat Mesencephalon by 1-Methyl-4-Phenylpyridinium: Cytochemical and Morphological EvidenceJournal of Neurochemistry, 1988
- Excitotoxity and the NMDA receptorTrends in Neurosciences, 1987
- V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- Glutamate: A Neurotransmitter in Mammalian BrainJournal of Neurochemistry, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium GlutamateScience, 1969